{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:09:14Z","timestamp":1777482554572,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670426"],"award-info":[{"award-number":["81670426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870336"],"award-info":[{"award-number":["81870336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cca.2019.06.022","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T12:35:15Z","timestamp":1561638915000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Goals of non-high density lipoprotein cholesterol need to be adjusted in Chinese acute coronary syndrome patients: Findings from the CCC-ACS project"],"prefix":"10.1016","volume":"496","author":[{"given":"Xin","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoquan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.cca.2019.06.022_bb0005","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD Risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"issue":"10015","key":"10.1016\/j.cca.2019.06.022_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","article-title":"Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the Global Burden of Disease Study 2013","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cca.2019.06.022_bb0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCULATIONAHA.117.032463","article-title":"Impact of novel low-density lipoprotein-cholesterol assessment on the utility of secondary non-high-density lipoprotein-C and apolipoprotein B targets in selected worldwide dyslipidemia guidelines","volume":"138","author":"Sathiyakumar","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cca.2019.06.022_bb0020","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.CIR.0000140668.91896.AE","article-title":"Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999","volume":"110","author":"Critchley","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.06.022_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2016.02.006","article-title":"The prevalence, awareness, treatment and control of dyslipidemia among adults in China","volume":"248","author":"Pan","year":"2016","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.cca.2019.06.022_bb0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.4358","article-title":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention","volume":"23","author":"Liu","year":"2017","journal-title":"Nat. Med."},{"issue":"2016","key":"10.1016\/j.cca.2019.06.022_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cca.2019.06.022_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"European society of, S. European atherosclerosis, ESC\/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cca.2019.06.022_bb0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacl.2013.12.006","article-title":"Non-HDL-cholesterol in an adolescent diabetes population","volume":"8","author":"Kuryan","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.cca.2019.06.022_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2018.05.010","article-title":"Non-HDL-C concentrations and residual cardiovascular risk: do population-specific precision approaches offer any advantages?","volume":"274","author":"Enkhmaa","year":"2018","journal-title":"Atherosclerosis"},{"issue":"22","key":"10.1016\/j.cca.2019.06.022_bb0055","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","article-title":"Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men","volume":"112","author":"Pischon","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cca.2019.06.022_bb0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","article-title":"Non-high-density lipoprotein cholesterol concentration as a predictor of cardiovascular disease mortality","volume":"161","author":"Cui","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"10.1016\/j.cca.2019.06.022_bb0065","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B concentrations with risk of cardiovascular events among patients treated with statins a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cca.2019.06.022_bb0070","first-page":"1263","article-title":"2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2019.06.022_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","article-title":"An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia - full report","volume":"8","author":"Grundy","year":"2014","journal-title":"J. Clin. Lipidol."},{"issue":"2","key":"10.1016\/j.cca.2019.06.022_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.cca.2019.06.022_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4356","article-title":"Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance","volume":"349","author":"Rabar","year":"2014","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.cca.2019.06.022_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008100","volume":"7","author":"Zhao","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"19","key":"10.1016\/j.cca.2019.06.022_bb0095","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"E. Expert Panel on Detection","year":"2001","journal-title":"Jama"},{"issue":"21","key":"10.1016\/j.cca.2019.06.022_bb0100","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jacc.2013.07.045","article-title":"Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids)","volume":"62","author":"Elshazly","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2019.06.022_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5551\/jat.33100","article-title":"Relationship between non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in the general population","volume":"23","author":"Kuwabara","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cca.2019.06.022_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2018.04.007","article-title":"Non-HDL-C goals based on the distribution of population percentiles in ELSA-Brasil: is it time to change?","volume":"274","author":"Brito","year":"2018","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.cca.2019.06.022_bb0115","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"C. Emerging Risk Factors","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cca.2019.06.022_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacl.2008.06.013","article-title":"The importance of non-HDL cholesterol reporting in lipid management","volume":"2","author":"Blaha","year":"2008","journal-title":"J. Clin. Lipidol."},{"issue":"21","key":"10.1016\/j.cca.2019.06.022_bb0125","doi-asserted-by":"crossref","first-page":"E393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans a scientific statement from the American Heart association","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cca.2019.06.022_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MOL.0000000000000067","article-title":"The composition and metabolism of large and small LDL","volume":"25","author":"Diffenderfer","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/j.cca.2019.06.022_bb0135","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amjcard.2012.10.037","article-title":"Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the limiting UNdertreatment of lipids in ACS with Rosuvastatin [LUNAR] trial)","volume":"111","author":"Ballantyne","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2019.06.022_bb0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2014.02.615","article-title":"Very low concentrations of atherogenic lipoproteins and the risk for cardiovascular events a meta-analysis of statin trials","volume":"64","author":"Boekholdt","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2019.06.022_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4158\/EP161682.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm-2017 executive summary","volume":"23","author":"Garber","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2019.06.022_bb0150","first-page":"1","article-title":"Validation of the Friedewald formula for estimating low density lipoprotein cholesterol: the Korea National Health and Nutrition Examination Survey, 2009 to 2011","volume":"21","author":"Lee","year":"2018","journal-title":"Korean J. Intern. Med."},{"issue":"2","key":"10.1016\/j.cca.2019.06.022_bb0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2003.09.028","article-title":"The metabolic syndrome and risk of major coronary events in the Scandinavian simvastatin survival study (4S) and the Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TexCAPS)","volume":"93","author":"Girman","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"14","key":"10.1016\/j.cca.2019.06.022_bb0160","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2019.06.022_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12872-016-0450-9","article-title":"Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol?: A retrospective study","volume":"17","author":"Wongcharoen","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cca.2019.06.022_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.10.012","article-title":"Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention","volume":"279","author":"Lee","year":"2018","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cca.2019.06.022_bb0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.atherosclerosis.2013.03.012","article-title":"Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the multi-ethnic study of atherosclerosis","volume":"229","author":"Degoma","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811931931X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811931931X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:16:54Z","timestamp":1777385814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811931931X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"alternative-id":["S000989811931931X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.06.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Goals of non-high density lipoprotein cholesterol need to be adjusted in Chinese acute coronary syndrome patients: Findings from the CCC-ACS project","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}